Benlysta 120 mg and 400 mg powder for concentrate for solution for infusion

Pharmacy Only: Prescription
  • Company:

    GlaxoSmithKline (Ireland) Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form EU/1/11/700/001-002 120 milligram(s) L04AA,L04AA26 Powder for Solution for infusion